Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer. (Credit: Philippe Delavie from Pixabay)